Embedded Files
Mucosomes
Revolutionizing Platforms
Glycosylated Mucin Nanoparticles
Our technology introduces a new class of nanoparticles called "mucosomes" designed to optimize drug delivery at mucosal surfaces. Our technology represents a scalable platform and a unique drug delivery solution combining targeting and mucoadhesivity for conditions such as inflammatory and infective lung diseases, oncology, and other applications where mucosal targeting is critical.
We have developed a proprietary one-pot approach for synthesis and drug encapsulation using food industry by-products and offering a scalable solution.
Validated through rigorous testing, mucosomes demonstrates high stability, efficient encapsulation across various compounds, and no immunogenic or toxic effects.
Google Sites
Report abuse